Categories AlphaGraphs, Earnings, Health Care
A visual representation of Trxade Group (MEDS) Q1 2020 earnings
Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the market opens. The bottom-line soared by 44% as platform sales drove the top-line higher by 46%.
The company continued to expand its trading platform organically, with 305 new independent pharmacies registered in Q1 2020. The average purchases per pharmacy increased on the Trxade platform by 13.7% in the first quarter of 2020, when compared to the same year-ago quarter.
During Q1, the company took strategic measures to enhance its corporate position, uplisting its common stock to the Nasdaq Capital Market and engaging an investor relations firm to implement a comprehensive capital markets strategy.
Take a look at our Health Care articles here
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
